8/8/2019 Anesthesia & Gestosis 2004
1/30
8/8/2019 Anesthesia & Gestosis 2004
2/30
8/8/2019 Anesthesia & Gestosis 2004
3/30
The Study Of DexmedetomidineThe Study Of Dexmedetomidine
Versus Morphine For Pain AndVersus Morphine For Pain And
Blood Pressure Control AfterBlood Pressure Control AfterCesarean Section ForCesarean Section For
E.P.H. Gestotic PatientsE.P.H. Gestotic Patients
8/8/2019 Anesthesia & Gestosis 2004
4/30
Reem H. El-Kabarity, MDDepartment of Anesthesia.
Abdelmegeed I. Abdelmegeed, MD
Department of Ob/Gyn.
Ain Shams University,
Cairo, Egypt.
8/8/2019 Anesthesia & Gestosis 2004
5/30
Introduction:Introduction:
EPHEPH--Gestosis is a high riskGestosis is a high riskpregnancy condition. It is characterisedpregnancy condition. It is characterised
by Edema (abnormal body gain ofby Edema (abnormal body gain ofweight water retention), and/orweight water retention), and/orProteinuria (excretion of pathologicalProteinuria (excretion of pathologicalamounts of urinary proteins) and/oramounts of urinary proteins) and/orHypertension (elevated systolic andHypertension (elevated systolic anddiastolic blood pressure).diastolic blood pressure).
8/8/2019 Anesthesia & Gestosis 2004
6/30
3210
>180160-179140-159Less
than 140Systolic BP
(mmHg)
>110100-10990-99Less
than 90
Diastolic BP
(mmHg)
GeneralizedLegs
abdomen
Legs
edema
Occult
or legEdema
> 1 gm/litre
+++
> 0.5-1 gm/L
++
0.5 gm/L
+
Nil or
traceProteinuria
EL-Kabarity Modified Gestosis Index
8/8/2019 Anesthesia & Gestosis 2004
7/30
The current protocol of management of EPH-
Gestosis has the following principles:
11-- Team approachTeam approach..
22-- Obstetric intensive care management.Obstetric intensive care management.
33-- MgSoMgSo44 administration.administration.
44-- Control of hypertension.Control of hypertension.
55-- Termination of pregnancy after stabilizationTermination of pregnancy after stabilization
sof general condition.sof general condition.
66-- Control of pain to avoid emergence ofControl of pain to avoid emergence of
patient into convulsive fits.patient into convulsive fits.
8/8/2019 Anesthesia & Gestosis 2004
8/30
SelectiveSelective 2 adrenoreceptor agonist.2 adrenoreceptor agonist.
Half life 2.3hours.Half life 2.3hours.
DMED isDMED is Central and peripheral sympatholyticCentral and peripheral sympatholyticeffecteffect inhibit N.E. release.inhibit N.E. release.
Stimulates 2 adrenoceptorStimulates 2 adrenoceptor
spinal cordspinal cord in locus ceruleusin locus ceruleus
analgesia.analgesia. sedation.sedation.
8/8/2019 Anesthesia & Gestosis 2004
9/30
ObjectivesObjectives
Comparison betweenComparison between
dexmedetomidine anddexmedetomidine and
morphine for pain control andmorphine for pain control and
decrease of blood pressuredecrease of blood pressure
for EPHfor EPH--Gestotic patientsGestotic patientsafter C.S.after C.S.
8/8/2019 Anesthesia & Gestosis 2004
10/30
Patients and MethodsPatients and Methods
42 parturient ladies with severe EPH42 parturient ladies with severe EPH
Gestosis, antepartum and intrapartumGestosis, antepartum and intrapartumeclampsia delivered by C.S.eclampsia delivered by C.S.
MgSo4 (4 gm slowly iv as a loadingMgSo4 (4 gm slowly iv as a loading
dose then I gm/2hrs for24 hrs).dose then I gm/2hrs for24 hrs). They were randomized equally into twoThey were randomized equally into two
groups.groups.
8/8/2019 Anesthesia & Gestosis 2004
11/30
Group (I):Group (I): ReceivedReceived dexmedetomidinedexmedetomidine 11 g/kgg/kgoverover1010 minutes (loading) followed byminutes (loading) followed by 00..44
g/kg/hr forg/kg/hr for22 hours (maintenance) in the posthours (maintenance) in the post--anesthesia care unit (PACU).anesthesia care unit (PACU).
Group (II):Group (II): Received single bolus ofReceived single bolus ofmorphinemorphine
sulphatesulphate 00..0808 mg/kg.mg/kg. Both drugs were started intravenouslyBoth drugs were started intravenously 1010minutes before endof surgery.minutes before endof surgery.
Over two hours postoperatively in the PACU,Over two hours postoperatively in the PACU,the followingdata were registeredeverythe followingdata were registeredevery 1010minutes: HR,MAP,RR,Level of sedation andminutes: HR,MAP,RR,Level of sedation andanalgesia using the Visual Analogue Scoreanalgesia using the Visual Analogue Score
(VAS).(VAS).
8/8/2019 Anesthesia & Gestosis 2004
12/30
Exclusion CriteriaExclusion Criteria
History of psychiatric disorder on psychotropic medication.History of psychiatric disorder on psychotropic medication.
Organ failure Renal FailureOrgan failure Renal Failure
Hepatic FailureHepatic Failure
Respiratory FailureRespiratory Failure
Patients receiving Dexmedetomidine itself or other alpha 2Patients receiving Dexmedetomidine itself or other alpha 2
agonists as clonidine.agonists as clonidine.
Severe degrees of heart block as it causes bradycardia.Severe degrees of heart block as it causes bradycardia.
8/8/2019 Anesthesia & Gestosis 2004
13/30
Technique of AnaesthesiaTechnique of Anaesthesia
Calcuim channel blockers (10mg sublinguial).Calcuim channel blockers (10mg sublinguial).
MgSo4.MgSo4.
Continuous monitoring (ECG, NIBP,O2Continuous monitoring (ECG, NIBP,O
2saturation).saturation).
11--2mg/kg lidocaine before intubation.2mg/kg lidocaine before intubation.
5mg/kg soduim thiopental then succinyl choline5mg/kg soduim thiopental then succinyl choline
1mg/kg for intubation.1mg/kg for intubation.
8/8/2019 Anesthesia & Gestosis 2004
14/30
Post Anaesthetic Care Unit (PACU)Post Anaesthetic Care Unit (PACU)
OverOver22 hours postoperatively everyhours postoperatively every 1010 mins.mins.
The followingdata were registered:The followingdata were registered: HR, MAP,RRHR, MAP,RR
Addition of morphine doses.Addition of morphine doses.
Assessment of level of sedation andAssessment of level of sedation andanalgesia using Visual Analog Score (VAS).analgesia using Visual Analog Score (VAS).
8/8/2019 Anesthesia & Gestosis 2004
15/30
Demographicdata showedno statistically significantDemographicdata showedno statistically significantdifferencedifference (P>(P>00..0505).).
Group (I):
DMED
Group (II):
MorphineP Significance
Age (years)24.4
1.2 2
6.10
.8 > 0
.05 NS
Parity 0.91.3 0.81.1 > 0.05 NS
Gestational age at time
of T.O.P. (weeks) 35.32.3 34.21.8 > 0.05 NS
Body Mass Index
(kg/m2)28.01.3 27.41.9 > 0.05 NS
8/8/2019 Anesthesia & Gestosis 2004
16/30
Comparing bothgroupsComparing bothgroups as regards theas regards theintraoperative dataandthe hemodynamicvaluesintraoperative dataandthe hemodynamicvaluesbefore givingthe drug shows no statisticallybefore givingthe drug shows no statistically
significantdifferencesignificantdifferenceGroup (I)
DMED
Group (II)
MorphineP Significance
Operative time (min) 43.36.7 49.25.9 > 0.05 NS
End-tidal halothane (%) 0.60.3 0.70.2 > 0.05 NS
Crystalloids (ml) 1023257 1131303 > 0.05 NS
Estimated blood loss
(ml) 62690 709
104 > 0.05 NS
Heart rate (bpm) 8014 8518 > 0.05 NS
MAP (mmHg) 1018 1057 > 0.05 NS
8/8/2019 Anesthesia & Gestosis 2004
17/30
Heart rate (beats/min) values overHeart rate (beats/min) values over 1010 min aftermin afterinjection of the study drugs showed statisticalinjection of the study drugs showed statisticalsignificant difference(P
8/8/2019 Anesthesia & Gestosis 2004
18/30
MAP (mmHg) values overMAP (mmHg) values over 1010 min after injection showedmin after injection showedstatistical significant difference showed statisticalstatistical significant difference showed statistical
significant difference( P
8/8/2019 Anesthesia & Gestosis 2004
19/30
Heart rate (beats/min) value of the studied drugs inHeart rate (beats/min) value of the studied drugs inthe PACU showed statistical significant differencethe PACU showed statistical significant difference
( P
8/8/2019 Anesthesia & Gestosis 2004
20/30
MAP (mmHg) values of the studied drugsMAP (mmHg) values of the studied drugs showedshowedstatistical significant differencestatistical significant difference in the PACUin the PACU
( P
8/8/2019 Anesthesia & Gestosis 2004
21/30
Respiratory rate (breath/min) values of theRespiratory rate (breath/min) values of thestudied drugs in PACU showed no statisticalstudied drugs in PACU showed no statistical
difference ( P >difference ( P > 00..0505) .) .
0
5
10
15
20
0 30 60 90 120
DMED
Mor i
8/8/2019 Anesthesia & Gestosis 2004
22/30
Oxygen saturation (%) values of the studiedOxygen saturation (%) values of the studieddrugs in PACU showed no statistical differencedrugs in PACU showed no statistical difference
(P >(P > 00..0505):):
94
95
96
97
98
99
100
030
60
90
120
Ti ( i )
2
t
r
tion
(
)
DM ED
M or ine
8/8/2019 Anesthesia & Gestosis 2004
23/30
Cumulative added doses of morphine (mg) forCumulative added doses of morphine (mg) forcontrol of pain in the PACU was statisticallycontrol of pain in the PACU was statistically
significant in the morphine group.significant in the morphine group.
0
2
4
6
8
10
0 30 60 90 120
Time (min)
Dose
DMED
Morphine
8/8/2019 Anesthesia & Gestosis 2004
24/30
The mean total dose/patient of morphine (mg)The mean total dose/patient of morphine (mg)overover 22 hours period in the PACU washours period in the PACU was
statistically significant in the morphine group.statistically significant in the morphine group.
0
2
4
6
8
10
DMED Group Morphine Group
Dose
8/8/2019 Anesthesia & Gestosis 2004
25/30
The mean total dose/patient of morphine additions (mg)The mean total dose/patient of morphine additions (mg)in ward throughin ward through 22--1212 hours postoperatively washours postoperatively was
statistically significant in the morphine group.statistically significant in the morphine group.
8/8/2019 Anesthesia & Gestosis 2004
26/30
Discussion:Discussion:
EE22--receptors regulate the autonomic andreceptors regulate the autonomic andcardiovascular system.cardiovascular system.
They are located in locus ceruleus and dorsal hornThey are located in locus ceruleus and dorsal horn
of spinal cord leading to sedation and analgesia.of spinal cord leading to sedation and analgesia. Lawerence andDe Lange (Lawerence andDe Lange (19971997)) reported areported a
biphasic effect on hemodynamic after IV DMED.biphasic effect on hemodynamic after IV DMED.
Venn andGround(Venn andGround(20012001)) found that DMED is safefound that DMED is safe
and acceptable sedative agent in ICU patient forand acceptable sedative agent in ICU patient forsedation.sedation.
Aho andhis collegues(Aho andhis collegues(19911991)) concluded thatconcluded thatDMED relieves pain and opioid drug request afterDMED relieves pain and opioid drug request afterlaparoscopic tubal ligation.laparoscopic tubal ligation.
8/8/2019 Anesthesia & Gestosis 2004
27/30
Bhana andhis collegues (2000)Bhana andhis collegues (2000) showedshowed
sedative, analgesic and anxiolytic effectssedative, analgesic and anxiolytic effects
after IV DMED in post surgical patients inafter IV DMED in post surgical patients inICU.ICU.
Coursin andhis collegues (2001)Coursin andhis collegues (2001) foundfound
DMED stimulatesDMED stimulates EE22 receptors in locusreceptors in locuscerulus in spinal cord to provide sedationcerulus in spinal cord to provide sedation
and enhance analgesia.and enhance analgesia.
Arain and
Ebert (2002)Arain and
Ebert (2002) found also thatfound also thatadministration of DMED versus propofoladministration of DMED versus propofol
showed more sedation, lower MAP,showed more sedation, lower MAP,
improved analgesia in the recovery room.improved analgesia in the recovery room.
8/8/2019 Anesthesia & Gestosis 2004
28/30
In our study, we found that parturients receivingIn our study, we found that parturients receivingdexmedetomidine for postoperative Cesarean Sectiondexmedetomidine for postoperative Cesarean Section
pain and blood pressure control for EPHpain and blood pressure control for EPH--Gestosis hadGestosis had
significantly slower postoperative HR, decrease insignificantly slower postoperative HR, decrease in
MAP without intial increase.MAP without intial increase.
This may be due to small dose infused,This may be due to small dose infused,
increased duration of infusion and the ability of volatileincreased duration of infusion and the ability of volatile
anesthetics directly to relax vascular smooth muscles.anesthetics directly to relax vascular smooth muscles.Hence they required less morphine in the PACUHence they required less morphine in the PACU
compared with the control group who received onlycompared with the control group who received only
morphine.morphine.
SummarySummary
8/8/2019 Anesthesia & Gestosis 2004
29/30
ConclusionConclusion
The use of dexmedetomidine as a postoperativeC.S. analgesic resulted in significantly lessaddition of pain-relief medications, slower HR as
well as lower MAP than the other group thatreceived only morphine. These results may provethat dexmedetomidine is more advantageous andbeneficial for gestotic patients; who might be
jeopardized by the higher risk of postoperativepain, hypertension, tachycardia, respiratorydepression as well as the need of using larger doses of morphine.
8/8/2019 Anesthesia & Gestosis 2004
30/30